Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 68071-3934

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-3934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3934 9)

Label for Esomeprazole Magnesium 40 mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 90 capsules with details including NDC 68071-3934-9 and barcode. It states the product is prescription only and includes manufacturer and lot information, storage instructions, and warnings.*

FDA Label Image

Figure1 (Figure1)

Chemical structure of esomeprazole magnesium showing two esomeprazole molecules coordinated with a magnesium ion and three water molecules. The structure includes methoxy, methyl, pyridine, sulfoxide, and benzimidazole groups.*

FDA Label Image

Figure2 (Figure2)

A line chart depicting the percent of subjects maintaining a condition over six months. Four groups are compared: Esomeprazole 40 mg, 20 mg, 10 mg, and placebo. The y-axis shows percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6. The highest maintenance is shown for the 40 mg dose group.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the percent of participants maintaining a response over six months, comparing Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses against placebo. The x-axis represents months (1 to 6) and the y-axis represents percent maintained (0-100).*

FDA Label Image

Figure4 (Figure4)

A line chart comparing percent of patients symptom-free over 28 days among three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The X-axis shows Diary Day 0 to 28; the Y-axis shows percent symptom-free from 0 to 100%. The chart shows higher symptom-free rates for Esomeprazole 40 mg, followed by 20 mg, and lowest for placebo.*

FDA Label Image

Figure5 (Figure5)

A line graph depicting the percent of patients symptom-free over a 28-day diary period for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The graph shows improvement trends for both Esomeprazole doses compared to placebo over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.